We are live on ! Find out more
JNJ icon

Johnson & Johnson

1,976 hedge funds and large institutions have $198B invested in Johnson & Johnson in 2014 Q2 according to their latest regulatory filings, with 54 funds opening new positions, 732 increasing their positions, 972 reducing their positions, and 41 closing their positions.

New
Increased
Maintained
Reduced
Closed

32% more first-time investments, than exits

New positions opened: 54 | Existing positions closed: 41

8% more capital invested

Capital invested by funds: $185B → $198B (+$13.9B)

2% more funds holding in top 10

Funds holding in top 10: 675688 (+13)

0.49% more ownership

Funds ownership: 66.51%67% (+0.49%)

0% more funds holding

Funds holding: 1,9731,976 (+3)

25% less repeat investments, than reductions

Existing positions increased: 732 | Existing positions reduced: 972

26% less call options, than puts

Call options by funds: $1.09B | Put options by funds: $1.48B

Holders
1,976
Holders Change
+3
Holders Change %
+0.15%
% of All Funds
56.77%
Holding in Top 10
688
Holding in Top 10 Change
+13
Holding in Top 10 Change %
+1.93%
% of All Funds
19.76%
New
54
Increased
732
Reduced
972
Closed
41
Calls
$1.09B
Puts
$1.48B
Net Calls
-$385M
Net Calls Change
-$512M
Name Holding Trade Value Shares
Change
Change in
Stake
PMG
676
Private Management Group
California
$11.2M -$427K -4,220 -4%
PIA
677
Piedmont Investment Advisors
North Carolina
$11.2M +$1.78M +17,632 +20%
FIM
678
Frontier Investment Management
Texas
$11.2M -$1.62K -16 -0%
MBI
679
Montrusco Bolton Investments
Quebec, Canada
$11.1M +$865K +8,558 +9%
KFS
680
KMS Financial Services
Washington
$11.1M +$9.1K +90 +0.1%
BOK
681
Bank of Kentucky
Kentucky
$10.9M -$565K -5,588 -5%
FFBTD
682
First Financial Bank - Trust Division
Ohio
$10.9M -$203K -2,005 -2%
PDN
683
Pensionfund DSM Netherlands
Netherlands
$10.9M
III
684
Independent Investors Inc
New York
$10.8M -$131K -1,300 -1%
TAM
685
Trillium Asset Management
Massachusetts
$10.8M +$974K +9,640 +10%
MACM
686
March Altus Capital Management
Connecticut
$10.8M +$10.4M +102,768 New
DWT
687
Dorsey & Whitney Trust
South Dakota
$10.7M +$287K +2,837 +3%
MAP
688
Managed Asset Portfolios
Michigan
$10.7M -$72.8K -720 -0.7%
DDC
689
DF Dent & Co
Maryland
$10.7M -$91.2K -902 -0.9%
BOC
690
Barbara Oil Co
Illinois
$10.7M
LTI
691
Laffer Tengler Investments
Tennessee
$10.7M +$814K +8,051 +9%
CCMG
692
Clark Capital Management Group
Pennsylvania
$10.6M +$551K +5,456 +6%
EFS
693
Essex Financial Services
Connecticut
$10.6M +$209K +2,068 +2%
CFA
694
Carroll Financial Associates
North Carolina
$10.5M -$354K -3,502 -3%
VC
695
Vestor Capital
Illinois
$10.5M +$9.2K +91 +0.1%
ARMC
696
American Research & Management Company
Massachusetts
$10.5M -$285K -2,822 -3%
CC
697
Capital Counsel
New York
$10.5M -$95.2K -942 -0.9%
KRSITF
698
Kentucky Retirement Systems Insurance Trust Fund
Kentucky
$10.4M +$211K +2,086 +2%
LBG
699
Lloyds Banking Group
United Kingdom
$10.4M -$167M -1,652,540 -94%
LKIM
700
Lawson Kroeker Investment Management
Nebraska
$10.3M +$461K +4,557 +5%

JNJ Hedge Fund Activity: Q2 2014 in Review

1,976 of the 3,481 institutional investors tracked by Wall St. Rank reported a position in Johnson & Johnson (JNJ) for Q2 2014, worth a combined $198B — up 7.5% from $185B a quarter earlier.

Buyers outnumbered sellers: 54 funds opened new JNJ positions and 41 closed out — a net gain of 13 holders — while 732 added to existing stakes and 972 trimmed.

The largest buyer was Norges Bank, adding an estimated $2.09B. The largest seller was Grantham, Mayo, Van Otterloo & Co (GMO), cutting an estimated $331M.

  • 1,976 institutional investors held Johnson & Johnson (JNJ) as of Q2 2014, up from 1,973 in Q1 2014.
  • Funds reported $198B of Johnson & Johnson stock for Q2 2014, up 7.5% quarter-over-quarter.
  • 54 funds opened new Johnson & Johnson positions in Q2 2014 and 41 closed out, a net change of +13 holders.
  • The largest Johnson & Johnson buyer in Q2 2014 was Norges Bank, an estimated $2.09B added.
  • The largest Johnson & Johnson seller in Q2 2014 was Grantham, Mayo, Van Otterloo & Co (GMO), an estimated $331M sold.

Based on aggregated 13F filings for Q2 2014.